Benign endometrial lesions are common among breast cancer patients tre
ated with tamoxifen but also among healthy women taking this drug in a
breast cancer prevention trial. The most frequent; lesion is glandulo
cystic atrophy which seems specific for this drug. Endometrial polyps
are also very often seen but only a few of them could undergo malignan
t degeneration. Hyperplasia of the endometrium is more frequently repo
rted among tamoxifen patients than among control patients. (C) 1998 El
sevier Science Ltd. All rights reserved.